🇺🇸 FDA
Company

KAZIA

KAZIA THERAPEUTICS LTD

KZIA pharma USA

Quick answer

KAZIA is a pharma company (KZIA) headquartered in SYDNEY NSW, USA with 13 tracked pipeline programs.

Pipeline (13)

project

Abemaciclib

CDK Gene Mutation

Phase 2 · small_molecule · active

1 trials project

PAXALISIB

Primary Central Nervous System Lymphoma

Phase 2 · small_molecule · active

1 trials project

Paxalisib

Malignant Primary Gliomas

Phase 2 · small_molecule · active

1 trials project

Paxalisib

Childhood Cancer

Phase 2 · small_molecule · active

1 trials project

Paxalisib

Glioblastoma

Phase 2 · small_molecule · on_hold

1 trials project

Paxalisib (GDC-0084)

Glioblastoma, Adult

Phase 2 · small_molecule · completed

1 trials project

Trastuzumab

Breast Cancer

Phase 2 · small_molecule · terminated

1 trials project

EVT801

Solid Tumor, Adult

Phase 1 · small_molecule · completed

1 trials project

GDC-0084

Brain and Central Nervous System Tumors

Phase 1 · small_molecule · completed

1 trials project

GDC-0084

Brain Metastases

Phase 1 · small_molecule · active

1 trials project

Part A: Dose Escalation of Cantrixil

Ovarian Neoplasms

Phase 1 · small_molecule · completed

1 trials project

[14C]-Paxalisib Capsule

Healthy

Phase 1 · small_molecule · completed

1 trials project

idronoxil

Unspecified Adult Solid Tumor, Protocol Specific

Phase 1 · small_molecule · completed

1 trials

Patents (1)

patent

US 10370349

Functionalised benzopyran compounds and use thereof

Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)